Hit Aktie

Hit für 0 Euro bei ZERO ordern (zzgl. Spreads)

ISIN: JP3791960002

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
21.07.2025 14:30:00

This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% Upside

Investing in penny stocks -- companies with share prices under around $5 apiece -- could lead to monster returns over the long run. The flip side is that these corporations tend to carry above-average risk. It's challenging to determine which penny stocks might go on to deliver excellent performances and which will fade into utter insignificance.Perhaps looking at the opinion of Wall Street analysts can help. Many who cover a little-known biotech company called Iovance Biotherapeutics (NASDAQ: IOVA) are bullish on the stock. The drugmaker hit its 52-week low of $1.64 a few weeks ago, although it has rebounded somewhat since. Still, at $2.23 per share as of this writing, Iovance's average price target of $10.70 (according to Yahoo! Finance) implies an upside of almost 380%.But before you rush to purchase Iovance stock, let's dig in a little more and figure out whether it's worth your money.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Hit Co.,Ltd. Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Hit Co.,Ltd. Registered Shs 2 047,00 -4,57% Hit Co.,Ltd. Registered Shs